You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
|
|---|---|
| Published in |
BMC Cancer, September 2010
|
| DOI | 10.1186/1471-2407-10-478 |
| Pubmed ID | |
| Authors |
Stephanie E Combs, Meinhard Kieser, Stefan Rieken, Daniel Habermehl, Oliver Jäkel, Thomas Haberer, Anna Nikoghosyan, Renate Haselmann, Andreas Unterberg, Wolfgang Wick, Jürgen Debus |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| China | 1 | 1% |
| Germany | 1 | 1% |
| Belgium | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 84 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 16 | 18% |
| Researcher | 14 | 16% |
| Student > Bachelor | 9 | 10% |
| Other | 7 | 8% |
| Student > Master | 7 | 8% |
| Other | 14 | 16% |
| Unknown | 21 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 47% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Physics and Astronomy | 4 | 5% |
| Agricultural and Biological Sciences | 2 | 2% |
| Computer Science | 2 | 2% |
| Other | 8 | 9% |
| Unknown | 26 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2022.
All research outputs
#20,828,290
of 25,591,967 outputs
Outputs from BMC Cancer
#6,019
of 9,018 outputs
Outputs of similar age
#94,948
of 105,378 outputs
Outputs of similar age from BMC Cancer
#39
of 46 outputs
Altmetric has tracked 25,591,967 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,018 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,378 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.